ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990

Lombardi Center, Virgin Islands Collaborate On Patient Care

August 7, 1981

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983